Welcome to StartupBubble.news, where we bring you the latest breakthroughs in the startup world. In this edition of Startup Showcase, we’re thrilled to present ShareTek, an Arizona-based startup revolutionizing at home diagnostics for remote drug and alcohol testing. ShareTek’s cutting-edge products empower individuals to take control of their own health and recovery, all while ensuring reliable and accurate test results. Join us as we delve into the fascinating world of ShareTek and their transformative contributions to the field.
Empowering Recovery Through At Home Diagnostics
ShareTek, founded in 2019 and headquartered in Scottsdale, Arizona, is a visionary company that has reimagined the landscape of drug and alcohol testing. Their mission is to provide individuals with the tools and resources they need to support their recovery journeys, right from the comfort of their own homes. Led by CEO and Founder Steve Moak, the ShareTek team consists of passionate professionals who have personal connections to addiction, illness, crime, and redemption, driving their commitment to making a difference in people’s lives.
Revolutionary At Home DNA Confirmed Drug Test Kit
At the heart of ShareTek’s innovation lies their flagship product: the first-ever at home DNA confirmed drug test kit. This groundbreaking solution detects over 100 different substances, including designer drugs, benzodiazepines, antidepressants, nicotine, and even synthetic urine that may go undetected by traditional tests. By leveraging state-of-the-art DNA matching technology, ShareTek ensures the reliability of at home test results by matching DNA from saliva and urine samples.
According to Moak, the inspiration behind ShareTek’s at home DNA confirmed drug test kit arose from his personal experience with addiction. Recognizing the lack of access and tools available to support individuals in early recovery, Moak was determined to make a change. “I wanted to make testing more discrete,” shared Moak. “Our kit offers unparalleled privacy and accuracy, providing a dignified testing solution for individuals in need.”
Eliminating Stigmatizing Practices in Drug and Alcohol Testing
One of ShareTek’s primary objectives is to eliminate the need for observed collection in the drug and alcohol testing industry. Moak strongly believes that observed collection can be stigmatizing and retraumatizing for many clients, inhibiting their recovery progress. ShareTek aims to transform the industry by providing a less intrusive and more respectful alternative. Moak envisions a future where observed collection will be regarded as an outdated and unnecessary practice, replaced by ShareTek’s innovative at home diagnostics solutions.
Leaders in the At Home Diagnostics Industry
ShareTek’s rapid growth has been propelled by the increasing demand for at home services, particularly in the wake of the Covid-19 pandemic. As a result, ShareTek has emerged as the nation’s largest provider of DNA confirmed at home drug tests. Their commitment to accuracy, privacy, and convenience has earned them a reputation as a trusted and reliable partner for individuals, families, and healthcare professionals.
ShareTek’s pioneering contributions to the at home diagnostics field have transformed the way individuals approach drug and alcohol testing. By providing discreet, accurate, and accessible solutions, ShareTek empowers people to take control of their recovery journeys from the privacy of their own homes. With their unwavering dedication to eliminating stigmatizing practices and their commitment to revolutionizing the industry, ShareTek is poised to shape the future of at home diagnostics.
Looking to promote your brand to a targeted audience of startup founders, investors, and C-level executives? Check out our advertising opportunities and sponsored articles at StartupBubble.news! Reach out to us at [email protected] to discuss how we can help amplify your brand’s visibility and drive results. Don’t miss out on this opportunity to connect with our engaged readership. Contact us today!